肝硬変の追跡調査

基本情報

NCT ID

NCT03472742

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

19

治験依頼者名

Rohto Pharmaceutical Co., Ltd.

概要

This is a follow-up study to assess safety and preliminary clinical activity of ADR-001 in patients with liver cirrhosis (Child-Pugh score; Grade B) caused by Hepatitis C or Nonalcoholic Steatohepatitis. Patients who have already participated in the ADR-001-01 study and completed the last evaluation after 24 weeks of administration will be eligible to this study. Patients registered will continue follow-up observation and evaluate long-term safety and exploratory efficacy.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)